Evaluating the Newly Proposed ARDS Definition in Hospitalized Patients With COVID-19 Treated With High-Flow Nasal Oxygen

被引:1
|
作者
Isha, Shahin [1 ]
Olaizola, Gustavo [2 ,3 ]
Bisso, Indalecio Carboni [2 ]
Raavi, Lekhya [1 ]
Jonna, Sadhana [1 ]
Jenkins, Anna [1 ]
Hanson, Abby [1 ]
Kashyap, Rahul [1 ,4 ]
Monzon, Veronica [5 ]
Huespe, Ivan A. [2 ,3 ]
Sanghavi, Devang [1 ]
机构
[1] Mayo Clin, Jacksonville, FL USA
[2] Hosp Italiano Buenos Aires, Buenos Aires, Argentina
[3] Univ Buenos Aires, Buenos Aires, Argentina
[4] Well Span Hlth, York, PA USA
[5] Hosp Italiano Agustin Roca, Buenos Aires, Argentina
关键词
ARDS; coronavirus disease 2019; high-flow nasal cannula oxygen; oxygen saturation; critical care; RESPIRATORY-DISTRESS-SYNDROME;
D O I
10.4187/respcare.11933
中图分类号
R4 [临床医学];
学科分类号
1002 ; 100602 ;
摘要
Background: The new Global definition of ARDS recently introduced a subgroup known as non-intubated ARDS. This study aimed to assess the risk of progression from noninvasive oxygen support to intubation and ARDS severity based on the S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> among non-intubated subjects with ARDS. Methods: This retrospective study included subjects with COVID-19 admitted to 7 hospitals (5 in the United States and 2 in Argentina) from January 2020-January 2023. Subjects meeting the new non-intubated ARDS definition (high-flow nasal cannula [HFNC] with an S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> <= 315 [with S<INF>pO<INF>2</INF></INF> <= 97%] or a P<INF>aO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> <= 300 mm Hg while receiving >= 30 L/min O<INF>2</INF> via HFNC) were included. The study evaluated the proportion of subjects who progressed to intubation, severity levels using the S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> cutoff proposed in the new ARDS definition, and mortality. Results: Nine hundred sixty-five non-intubated subjects with ARDS were included, of whom 27% (n = 262) progressed to meet the Berlin criteria within a median of 3 d (interquartile range 2-6). The overall mortality was 23% (95% CI 20-26) (n = 225), and among subjects who progressed to the Berlin criteria, it was 37% (95% CI 31-43) (n = 98). Additionally, the worst S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> within 1 d of ARDS diagnosis was correlated with mortality, with mortality rates of 26% (95% CI 23-30) (n = 177) for subjects with S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> <= 148, 17% (95% CI 12-23) (n = 38) for those with S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> between 149-234, and 16% (95% CI 8-28) (n = 10) for subjects maintaining an S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> higher than 235 (P < .001). Conclusions: The non-intubated ARDS criteria encompassed a broader spectrum of subjects with lower in-hospital mortality compared to the Berlin criteria. The S<INF>pO<INF>2</INF></INF>/F<INF>IO<INF>2</INF></INF> and ARDS severity cutoff proposed in the new Global ARDS definition were valuable predictors of in-hospital mortality in these subjects.
引用
收藏
页码:119 / 125
页数:7
相关论文
共 50 条
  • [31] Prone positioning combined with high-flow nasal or conventional oxygen therapy in severe Covid-19 patients
    Despres, Cyrielle
    Brunin, Yannick
    Berthier, Francis
    Pili-Floury, Sebastien
    Besch, Guillaume
    CRITICAL CARE, 2020, 24 (01):
  • [32] Nasal high-flow oxygen therapy in COVID-19 patients does not cause environmental surface contamination
    Roca, O.
    Pacheco, A.
    Rodon, J.
    Anton, A.
    Vergara-Alert, J.
    Armadans, L.
    Segales, J.
    Pumarola, T.
    Campins, M.
    Ferrer, R.
    Rodriguez-Garrido, V.
    JOURNAL OF HOSPITAL INFECTION, 2021, 116 : 103 - 105
  • [33] High-Flow Nasal Cannula in Critically Ill Patients with Severe COVID-19
    Demoule, Alexandre
    Baron, Antoine Vieillard
    Darmon, Michael
    Beurton, Alexandra
    Geri, Guillaume
    Voiriot, Guillaume
    Dupont, Thibault
    Zafrani, Lara
    Girodias, Lola
    Labbe, Vincent
    Dres, Martin
    Fartoukh, Muriel
    Azoulay, Elie
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2020, 202 (07) : 1039 - 1042
  • [34] The effects of high-flow oxygen therapy on mortality in patients with COVID-19
    Bianchi, Mia
    JOURNAL OF THE AMERICAN ASSOCIATION OF NURSE PRACTITIONERS, 2023, 35 (03) : 183 - 191
  • [35] Clinical experience with high-flow nasal cannula for COVID-19 patients in Japan
    Katsuno, Takashi
    Suzuki, Manabu
    Hojo, Masayuki
    Takasaki, Jin
    Sugiyama, Haruhito
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [36] High-Flow Nasal Cannula Versus Noninvasive Ventilation in Patients With COVID-19
    Beran, Azizullah
    Srour, Omar
    Malhas, Saif-Eddin
    Mhanna, Mohammed
    Ayesh, Hazem
    Sajdeya, Omar
    Musallam, Rami
    Khokher, Waleed
    Kalifa, Muhamad
    Srour, Khaled
    Assaly, Ragheb
    RESPIRATORY CARE, 2022, 67 (09) : 1177 - 1189
  • [37] dCROX and ROX Indices Predict Clinical Outcomes in Patients with COVID-19 Pneumonia Treated with High-Flow Nasal Cannula Oxygen Therapy
    Ruchiwit, Pitchayapa
    Pongtongkam, Kanpisut
    Saiphoklang, Narongkorn
    CRITICAL CARE RESEARCH AND PRACTICE, 2024, 2024
  • [38] dCROX and ROX indices predict clinical outcomes in patients with COVID-19 pneumonia treated with high-flow nasal cannula oxygen therapy
    Ruchiwit, Pitchayapa
    Pongtongkam, Kanpisut
    Saiphoklang, Narongkorn
    RESPIROLOGY, 2023, 28 : 86 - 87
  • [39] Predicting Success of High-Flow Nasal Cannula in COVID-19
    Varipapa, Robert J., Jr.
    Sonti, Rajiv
    RESPIRATORY CARE, 2021, 66 (06) : 1044 - 1045
  • [40] PREDICTORS OF HIGH-FLOW NASAL CANNULA FAILURE IN COVID-19
    Gregory, Ismail
    Bhavani, Sivasubramanium
    Yang, Philip
    Robichaux, Chad
    CRITICAL CARE MEDICINE, 2023, 51 (01) : 553 - 553